BIOMAT Database Logo BIOMAT Database Logo

Structure-activity relationships of epolactaene analogs as DNA polymerases inhibitors. 2004

Kouji Kuramochi, and Yoshiyuki Mizushina, and Seigo Nagata, and Fumio Sugawara, and Kengo Sakaguchi, and Susumu Kobayashi
Frontier Research Center for Genome and Drug Discovery, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan.

Epolactaene, a neuritogenic compound in human neuroblastoma cells, showed inhibitory activities against DNA polymerases alpha and beta. The synthesis and inhibitory activities of epolactaene analogs are described. The alpha,beta-epoxy-gamma-lactam moiety in the core and the length of the side chain greatly influenced the activities. Compound 5 was the strongest inhibitor of DNA polymerase alpha and beta of all synthesized compounds with IC(50) values of 13 and 78 microM, respectively. N- and O-alkyl derivatives that had modified core moieties showed moderate inhibition.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011090 Polyenes Hydrocarbons with more than one double bond. They are a reduced form of POLYYNES. Cumulenes
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D004852 Epoxy Compounds Organic compounds that include a cyclic ether with three ring atoms in their structure. They are commonly used as precursors for POLYMERS such as EPOXY RESINS. Epoxide,Epoxides,Epoxy Compound,Oxiranes,Compound, Epoxy,Compounds, Epoxy
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013055 Spectrophotometry, Infrared Spectrophotometry in the infrared region, usually for the purpose of chemical analysis through measurement of absorption spectra associated with rotational and vibrational energy levels of molecules. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) IR Spectra,Infrared Spectrophotometry,IR Spectras,Spectra, IR
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D019384 Nucleic Acid Synthesis Inhibitors Compounds that inhibit cell production of DNA or RNA. DNA Polymerase Inhibitor,DNA Synthesis Inhibitor,DNA Synthesis Inhibitors,Nucleic Acid Synthesis Inhibitor,RNA Synthesis Inhibitor,RNA Synthesis Inhibitors,DNA Polymerase Inhibitors,Inhibitors, DNA Synthesis,Inhibitors, Nucleic Acid Synthesis,Inhibitors, RNA Synthesis,Inhibitor, DNA Polymerase,Inhibitor, DNA Synthesis,Inhibitor, RNA Synthesis,Inhibitors, DNA Polymerase,Polymerase Inhibitor, DNA,Polymerase Inhibitors, DNA,Synthesis Inhibitor, DNA,Synthesis Inhibitor, RNA,Synthesis Inhibitors, DNA,Synthesis Inhibitors, RNA

Related Publications

Kouji Kuramochi, and Yoshiyuki Mizushina, and Seigo Nagata, and Fumio Sugawara, and Kengo Sakaguchi, and Susumu Kobayashi
Deoxyribonucleotide analogs as inhibitors and substrates of DNA polymerases.
January 1990, Pharmacology & therapeutics,
Kouji Kuramochi, and Yoshiyuki Mizushina, and Seigo Nagata, and Fumio Sugawara, and Kengo Sakaguchi, and Susumu Kobayashi
Structure-Activity Relationships of Baicalein and its Analogs as Novel TSLP Inhibitors.
June 2019, Scientific reports,
Kouji Kuramochi, and Yoshiyuki Mizushina, and Seigo Nagata, and Fumio Sugawara, and Kengo Sakaguchi, and Susumu Kobayashi
Structure-activity relationships of synthetic analogs of (-)-epigallocatechin-3-gallate as proteasome inhibitors.
January 2004, Anticancer research,
Kouji Kuramochi, and Yoshiyuki Mizushina, and Seigo Nagata, and Fumio Sugawara, and Kengo Sakaguchi, and Susumu Kobayashi
Structure-activity relationships of epolactaene derivatives: structural requirements for inhibition of Hsp60 chaperone activity.
September 2004, Bioorganic & medicinal chemistry letters,
Kouji Kuramochi, and Yoshiyuki Mizushina, and Seigo Nagata, and Fumio Sugawara, and Kengo Sakaguchi, and Susumu Kobayashi
Structure-activity relationships in DNA gyrase inhibitors.
January 1990, Pharmacology & therapeutics,
Kouji Kuramochi, and Yoshiyuki Mizushina, and Seigo Nagata, and Fumio Sugawara, and Kengo Sakaguchi, and Susumu Kobayashi
Author Correction: Structure-Activity Relationships of Baicalein and its Analogs as Novel TSLP Inhibitors.
January 2020, Scientific reports,
Kouji Kuramochi, and Yoshiyuki Mizushina, and Seigo Nagata, and Fumio Sugawara, and Kengo Sakaguchi, and Susumu Kobayashi
Function and structure relationships in DNA polymerases.
January 1994, Annual review of biochemistry,
Kouji Kuramochi, and Yoshiyuki Mizushina, and Seigo Nagata, and Fumio Sugawara, and Kengo Sakaguchi, and Susumu Kobayashi
Quantitative structure-activity relationships for cycloguanil analogs as PfDHFR inhibitors using mathematical molecular descriptors.
April 2010, SAR and QSAR in environmental research,
Kouji Kuramochi, and Yoshiyuki Mizushina, and Seigo Nagata, and Fumio Sugawara, and Kengo Sakaguchi, and Susumu Kobayashi
Synthesis and structure-activity relationships of ticlopidine derivatives and analogs as inhibitors of ectonucleotidase CD39.
June 2023, Bioorganic chemistry,
Kouji Kuramochi, and Yoshiyuki Mizushina, and Seigo Nagata, and Fumio Sugawara, and Kengo Sakaguchi, and Susumu Kobayashi
Felodipine analogs: structure-activity relationships.
January 1987, Journal of cardiovascular pharmacology,
Copied contents to your clipboard!